Add Yahoo as a preferred source to see more of our stories on Google. Part B aims to expand clinical indications for OCS Heart to include standard criteria DBD hearts transplanted within four hours.

In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn't get the organ to a recipient in time.

A new medical technology expected to be on the market in 2027 is poised to help patients in middle America have greater ...

TransMedics Group (NasdaqGM:TMDX) received full FDA approval for its Next-Generation OCS ENHANCE Heart trial. The decision clears a key regulatory hurdle for the company’s heart-focused organ care ...

In the majority of cases, graft failure after heart transplantation is attributable to abnormalities like severe coronary artery disease. As donors with extended criteria like advanced age and ...

Please provide your email address to receive an email when new articles are posted on . Most respondents reported they would undergo a donation procedure that maximized use of their organs. Many ...

On 20 February 2026, Orrum Clinical Analytics announced a partnership with LivaNova USA Inc. to link LivaNova’s Essenz Perfusion System with Orrum’s CORE Insights platform, enabling secure, automatic ...

The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...